Evidence map›Paper›PMID 37069649›Full record

ReviewBiomarker research2023

Novel insights into the multifaceted roles of m

Jinxin Tang, Jinhui Zhang, Yu Lu, Jieyu He, Hua Wang, Binfeng Liu, Chao Tu, Zhihong Li

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomarker research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. mMolecules (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Enhancing mHeliyon · 2024
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jinxin TangDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Jinhui ZhangXiangya School of Medicine, Central South University, Changsha, Hunan, 410011, China.
Yu LuXiangya School of Medicine, Central South University, Changsha, Hunan, 410011, China.
Jieyu HeDepartment of Geriatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Hua WangDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Binfeng LiuDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Chao TuDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. tuchao@csu.edu.cn.
Zhihong LiDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. lizhihong@csu.edu.cn.
Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

Hunan Provincial Administration of Traditional Chinese Medicine Project D2022117Hunan Provincial Natural Science Foundation of China 2022JJ30843National Natural Foundation of China 82272664, 81902745the Rehabilitation Project of Hunan Disabled Persons' Federation 2022XK0215the Science and Technology Development Fund Guided by Central Government 2021Szvup169the Scientific Research Program of Hunan Provincial Health Commission B202304077077
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

BiomarkerCancerLncRNAm6A-modificationSarcoma

Identifiers

PMID37069649
PMCPMC10111779
OpenAlexW4366086079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.